Neurocrine Biosciences, Inc. (BIT:1NBIX)

Neurocrine Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	348.3	341.3	249.7	154.5	89.6	407.3
Depreciation & Amortization	28.5	27.1	21.3	15.6	10.9	8.6
Other Amortization	-138.4	-	-	-	17.3	21.4
Loss (Gain) From Sale of Investments	36	10.9	-46.7	-27.1	-13.5	17.7
Stock-Based Compensation	213.5	195.5	194.3	173.1	134.2	100
Other Operating Activities	56.8	39.8	-56.9	90.7	1.3	-288.6
Change in Accounts Receivable	-127.5	-39.8	-89.3	-162.2	-28.4	-30.5
Change in Inventory	-14.5	-19.1	5.4	-2.6	-2.5	-10.7
Change in Accounts Payable	135	29	64.3	114.6	56.8	26.9
Change in Other Net Operating Assets	42.9	10.7	47.8	-17.2	-9.2	-23.6
Operating Cash Flow	567.3	595.4	389.9	339.4	256.5	228.5
Operating Cash Flow Growth	6.96%	52.71%	14.88%	32.32%	12.25%	55.44%
Capital Expenditures	-38.6	-38.2	-28.3	-16.5	-23.4	-10.9
Cash Acquisitions	-	-	-	-42.7	-	-
Investment in Securities	-19.8	-88.6	-438.8	-117.9	-106.8	15
Investing Cash Flow	-58.4	-126.8	-467.1	-177.1	-130.2	4.1
Long-Term Debt Repaid	-	-308.8	-	-279	-0.1	-186.9
Net Debt Issued (Repaid)	-	-308.8	-	-279	-0.1	-186.9
Issuance of Common Stock	82.9	122.1	65.3	44.7	27.5	29.1
Repurchase of Common Stock	-467.7	-300	-	-	-	-
Financing Cash Flow	-384.8	-486.7	65.3	-234.3	27.4	-157.8
Foreign Exchange Rate Adjustments	0.2	-	0.3	-1.3	-	-
Net Cash Flow	124.3	-18.1	-11.6	-73.3	153.7	74.8
Free Cash Flow	528.7	557.2	361.6	322.9	233.1	217.6
Free Cash Flow Growth	6.89%	54.09%	11.98%	38.52%	7.12%	64.48%
Free Cash Flow Margin	21.07%	23.66%	19.16%	21.69%	20.57%	20.80%
Free Cash Flow Per Share	5.15	5.37	3.58	3.27	2.38	2.23
Cash Interest Paid	-	1.6	3.8	6.6	8.6	11.6
Cash Income Tax Paid	197.2	217.5	51.5	14.4	5.1	15.3
Levered Free Cash Flow	367.04	457.98	439.25	247.63	265.75	278.59
Unlevered Free Cash Flow	505.44	457.98	439.25	247.63	264.58	277.69
Change in Working Capital	35.9	-19.2	28.2	-67.4	16.7	-37.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.